Fine-tuning treatments for depressionOctober 19, 2009CHICAGO -- New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression. Current drugs for depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases. Recent findings suggest that synucleins, a family of small proteins in the brain, are key players in the management of neurotransmitters -- specifically, alpha- and gamma-synuclein. Additionally, researchers have found elevated levels of gamma-synuclein in the brains of both depressed animals and humans. In a study presented at the 39th annual meeting of the Society for Neuroscience, Georgetown University Medical Center researchers observed increased depressive-like behavior in mice where gamma-synuclein acts alone to regulate neurotransmitters, confirming earlier studies by this group. "These findings show the importance of, and clarify a functional role for, gamma synuclein in depression and may provide new therapeutic targets in treatment of this disease," says Adam Oaks, a student researcher in the Laboratory of Molecular Neurochemistry at GUMC. "Understanding how current therapies work with the synucleins is important because the drugs don't work for all patients, and some are associated with side effects including an increased risk of suicide." Georgetown University Medical Center |
|||||||||||||||||||||
| Related Neurotransmitters Current Events and Neurotransmitters News Articles Changes in brain chemicals mark shifts in infant learning When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world. Why antidepressants don't work for so many More than half the people who take antidepressants for depression never get relief. Antidepressants: benefit of SNRI is proven The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) drug class. Excessive exercise can be addicting, new study says Although exercise is good for your health, extreme exercise may be physically addicting. Rats given a drug that produces withdrawal in heroin addicts went into withdrawal after running excessively in exercise wheels, according to new research. Rats that ran the hardest had the most severe withdrawal symptoms. Live recordings of cell communication A new advanced method for nano-scale imaging of vesicle-fusion - vesicles are biological nano-sized containers - could add to our understanding of diseases of the nervous system and viral infections. UCLA scientists present first genetic evidence for why placebos work Placebos are a sham - usually mere sugar pills designed to represent "no treatment" in a clinical treatment study. The effectiveness of the actual medication is compared with the placebo to determine if the medication works. One step closer to an artificial nerve cell Scientists at the Swedish medical university Karolinska Institutet and Linköping University are well on the way to creating the first artificial nerve cell that can communicate specifically with nerve cells in the body using neurotransmitters. ADHD genes found, known to play roles in neurodevelopment Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD. Mouse model of Parkinson's reproduces nonmotor symptoms The classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. Over the last decade, neurologists have been paying greater attention to non-motor symptoms, such as digestive and sleep problems, loss of sense of smell and depression. UBC researchers develop new method to study gambling addictions UBC researchers have created the world's first animal laboratory experiment to successfully model human gambling. More Neurotransmitters Current Events and Neurotransmitters News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||